AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study
Autoři | |
---|---|
Rok publikování | 2020 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Frontiers in bioengineering and biotechnology |
Fakulta / Pracoviště MU | |
Citace | |
www | https://www.frontiersin.org/articles/10.3389/fbioe.2020.552357/full |
Doi | http://dx.doi.org/10.3389/fbioe.2020.552357 |
Klíčová slova | pulsed field ablation; irreversible electroporation (IRE); radiofrequency ablation; atrial fibrillation; ventricular arrhythmia (VA); preclinical cardiology |
Popis | Pulsed field ablation (PFA) exploits the delivery of short high-voltage shocks to induce cells death via irreversible electroporation. The therapy offers a potential paradigm shift for catheter ablation of cardiac arrhythmia. We designed an AC-burst generator and therapeutic strategy, based on the existing knowledge between efficacy and safety among different pulses. We performed a proof-of-concept chronic animal trial to test the feasibility and safety of our method and technology. |
Související projekty: |